GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹7,157 Cr | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr |
What is the latest Profit & Loss Account Balance ratio of GLAND PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹7,157 Cr |
| Mar2024 | ₹6,788 Cr |
| Mar2023 | ₹6,015 Cr |
| Mar2022 | ₹5,234 Cr |
| Mar2021 | ₹4,023 Cr |
How is Profit & Loss Account Balance of GLAND PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,157 Cr | 5.44 | |
| Mar2024 | ₹6,788 Cr | 12.84 | |
| Mar2023 | ₹6,015 Cr | 14.92 | |
| Mar2022 | ₹5,234 Cr | 30.12 | |
| Mar2021 | ₹4,023 Cr | - | |
Compare Profit & Loss Account Balance of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹29,571.7 Cr | 3.2% | 10.3% | 24.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,209.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,750.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,746.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,851.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹99,268.4 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 3.2% |
10.3% |
24.6% |
| SENSEX | 1.3% |
5.3% |
6.3% |
You may also like the below Video Courses